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In orthopaedic medicine, connective tissues are often affected by traumatic or degen-
erative injuries, and surgical intervention is required. Rotator cuff tears are a common
cause of shoulder pain and disability among adults. The development of graft
materials for bridging the gap between tendon and bone after chronic rotator cuff
tears is essentially required. The limiting factor for the clinical success of a tissue
engineering construct is a fast and complete vascularization of the construct. Other-
wise, immigrating cells are not able to survive for a longer period of time, resulting in
the failure of the graft material. The femur chamber allows the observation of
microhaemodynamic parameters inside implants located in close vicinity to the femur
in repeated measurements in vivo. We compared a porous polymer patch (a commer-
cially available porous polyurethane‐based scaffold from Biomerix™) with electrospun
polycaprolactone (PCL) fibre mats and chitosan (CS)‐graft‐PCL modified electrospun
PCL (CS‐g‐PCL) fibre mats in vivo. By means of intravital fluorescence microscopy,
microhaemodynamic parameters were analysed repetitively over 20 days at intervals
of 3 to 4 days. CS‐g‐PCL modified fibre mats showed a significantly increased vascu-
larization at Day 10 compared with Day 6 and at Day 14 compared with the porous
polymer patch and the unmodified PCL fibre mats at the same day. These results
could be verified by histology. In conclusion, a clear improvement in terms of vascu-
larization and biocompatibility is achieved by graft‐copolymer modification compared
with the unmodified material.
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GNIESMER ET AL. 11911 | INTRODUCTION
In orthopaedic medicine, connective tissues are often affected by
traumatic or degenerative injuries, and surgical intervention is
required. Rotator cuff tears are a common cause of shoulder pain
and disability among adults. The aetiopathogenesis of rotator cuff
tears is not resolved finally. Several theories concerning the reasons
of rotator cuff tears distinguishing between extrinsic and intrinsic fac-
tors were discussed in Giai Via, De Cupis, Spoliti, and Oliva (2013). In
addition to the unknown aetiopathogenesis of rotator cuff tears, the
healing process in tendon‐to‐bone interfaces is very slow because of
low vascularization in tendon tissue. Thereby, the nutrition and the
removal of inflammatory products are impeded. At the present time,
several strategies for the management of rotator cuff injuries are
discussed, but numerous attempts to rebuild the transition zone and
to restore a functional enthesis have been shown to be unsuccessful
(Boileau et al., 2005; Jost, Zumstein, Pfirrmann, & Gerber, 2006). The
structure of the transition zone between tendon and bone, called
enthesis, is mechanically and biologically complex. The importance of
this structure arises from its function. The attachment of two dissimi-
lar materials results in stress singularities at their interface. The transi-
tional tissue of the enthesis that shows structural and compositional
gradients reduces stress concentrations and warrants an optimal
transmission of forces between the stiff, brittle bone, and the tough,
extensible tendon (Zelzer, Blitz, Killian, & Thomopoulos, 2014; Lu &
Thomopoulos, 2013). The fibrocartilaginous enthesis in the rotator
cuff is classified in four distinct zones of tissue with a structurally con-
tinuous gradient from uncalcified tendon to uncalcified fibrocartilage
to calcified fibrocartilage to calcified bone. The junctions between dis-
tinct tissue types are prone to injury, and unfortunately, their recovery
following surgical repair is only poor. Injuries are more frequent in
fibrocartilaginous enthesis than in fibrous insertions (Apostolakos
et al., 2014).
During the early healing process, the tendon‐to‐bone junction is
not resilient, because the complex tendon‐to‐bone‐construct is
replaced by fibrotic tissue. After months and weeks, the biomechanical
strength increases due to the remodelling process at the tendon‐to‐
bone junction (Gulotta, Kovacevic, Packer, Deng, & Rodeo, 2011).
However, the healing process results solely in a repair of the damaged
junction, thus leading to the formation of scar tissue and not in the
regeneration of the naturally occurring tendon‐to‐bone interface with
its organized distinct composition of four zones (Rodeo, 2007).
In case of a chronic rotator cuff tear, the typically long latency
between occurrence, diagnosis, and treatment leads to chronic
changes in the musculotendinous unit. Muscle atrophy and fatty infil-
trations of the muscle arise through the loss of muscle activity and the
loss of pretension (Gerber, Meyer, Schneeberger, Hoppeler, & Von
Rechenberg, 2004; Gerber et al., 2009). Consecutively, the tendon
retracts, and surgical repair is complicated (Meyer, Wieser, Farshad,
& Gerber, 2012). To accomplish surgical tendon repair, the gap
between bone and tendon must be bridged by applying tension to
extend the tendon, or the gap has to be closed by augmentation with
a graft (Meyer, Gerber, von Rechenberg, Wirth, & Farshad, 2011). Allimplantations lead to an inflammatory response either because of
the surgical trauma or as a reaction to the implant itself. The inflamma-
tory response is based on the well‐known foreign body reaction
depending on the material and its surface characteristics. To reduce
this reaction, implants can be modified with coatings or used as car-
riers for medication and growth factors (Ferracini et al., 2018). The
used materials must be biocompatible to prevent adverse immunolog-
ical reaction. Additionally, the structure of implants is of great
importance for cells to attach, proliferate, and migrate. The survival
of the implant and thus the success of the therapy after implant place-
ment are dependent on the migration of the cells and their supply with
oxygen and nutrients as well as the removal of waste (Lovett, Lee,
Edwards, & Kaplan, 2009). Therefore, the key factor is adequate
angiogenesis, especially in the early stages after implantation. Previous
in vivo investigations of angiogenic processes after the application of
implants were carried out mostly in soft tissue models, such as the
dorsal skinfold chamber (Rücker et al., 2006). Recently, different hard
tissue models like the cranial window have been described (Sinikovic
et al., 2011). With respect to orthopaedic applications, the examina-
tion of implants in the area of long tubular bones is more appropriate.
The femur chamber model in mice allows the assessment of the
microcirculation in a femoral defect model in immediate vicinity of
the bone (Tavassol et al., 2011). In this study, we adapted this model
to allow the application in rats without a bone defect. Therewith,
information about angiogenesis can be given in the target area of
orthopaedic implants.
Implants, which are not intended to remain permanently in the
body and difficult to remove after healing, should be biodegradable
without toxic remains. The rate of degradation should correspond to
the rate of tissue restoration. The physiological situation at the defect
site should be restored by invading cells in the long term whereas the
implant is transformed into harmless degradation products that can be
metabolized.
In line with these arguments, polycaprolactone (PCL) is used in
various biomedical applications because of its biocompatibility,
adequate mechanical properties, and slow degradation in vivo (Lam,
Hutmacher, Schantz, Woodruff, & Teoh, 2008; Dash & Konkimalla,
2012). PCL can be processed by electrospinning, which allows a con-
trolled design of fibre alignment, porosity, fibre diameter, and pore
size (Font Tellado, Balmayor, & Griensven, 2015). Although PCL is
biocompatible, its surface is hydrophobic and thus not particularly
attractive for cell attachment and growth (Venugopal, Ma, Yong, &
Ramakrishna, 2005). Therefore, PCL is unattractive for biomedical
applications (Nair & Laurencin, 2007). Furthermore, because PCL is
an aliphatic polyester, it lacks access to easy modifications, and
chemically more reactive moieties have to be introduced by various
approaches such as plasma or wet chemical treatment, blending,
and attachment of graft copolymers (Fu, Sammons, Bertóti, Jenkins,
& Dong, 2011; Tallawi et al., 2015; de Cassan et al., 2018). These
modifications can help overcome these weaknesses of PCL, while
maintaining good properties, and create implants applicable in a vari-
ety of orthopaedic areas, for example, the use in therapy of chronic
rotator cuff tears.
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ization and biocompatibility of PCL‐based implants in the hard tissue
model of femur chamber in rats, in comparison with commercially
available implant material.2 | MATERIALS AND METHODS
2.1 | Implants
For the experimental groups, electrospun fibre mats were produced by
electrospinning of poly‐ε‐caprolactone (Mn = 80,000, Sigma‐Aldrich
Chemie GmbH, Taufkirchen, Germany; PCL) and trifluoroethanol (abcr
GmbH, Karlsruhe, Germany). A PCL solution of 170 mg/ml in
trifluoroethanol was loaded into a 10‐ml syringe (B. Braun, Melsungen,
Germany) connected by polyethylene tubing to an electrospinning
emitter (B. Braun Needle 8 G, blunt tip, Melsungen, Germany). A rotat-
ing steel drum covered with aluminium foil served as a collector. The
scaffolds were produced with 2 m/s for unorientated fibres. The
voltage was set to 25 kV and the emitter to collector distance to
25 cm. The fibre mat thickness of 300 μm arose from the solution flow
rate of 4 ml/hr.
As a second experimental group, the same PCL fibre mats were
additionally modified with chitosan, called chitosan‐g‐PCL. For synthe-
sis, chitosan‐PCL graft copolymers were crystallized on PCL
nanofibres, as described recently (de Cassan et al., 2018). Thereby,
chitosan is presented at the surface of the fibre.
As a control group, a commercially available porous polymer scaf-
fold (Biomerix RCR Patch, Biomerix Corporation, Somerset, USA; pur-
chased from Cellon, Bascharage, Luxembourg; Encalada‐Diaz et al.,
2011) was used. This biocompatible scaffold has an interconnected
3D network of pores with a pore size of 100 to 250 μm. The material
is designed to mimic the nature and function of the extracellular
matrix for regenerative medicine research (Encalada‐Diaz et al.,
2011). For further characterization, scaffolds of each group were
stamped with a circular cutter to a diameter of 15 (mass analysis)
and 25 mm (porosity). In the case of fibre mats, material for the
implants as well as for the further characterization is obtained from
the middle area. In this area, the structure of the fibre mats is more
homogeneous than in the peripheral areas.
For in vivo experiments, scaffolds of each group were cut into
pieces of 3 × 5 mm and shrink‐wrapped in sterilization pouches
(SteriClin, Vereinigte Papierwarenfabriken, Feuchtwangen, Germany).
The sterilization was performed by beta radiation with a dose of
25 kGy (using a Rhodotron TT 100 e‐beam accelerator, Mediscan,
Kremsmünster, Austria).2.2 | Evaluation of porosity and pore diameter
The porosity of the fibrous scaffolds was determined by the gravimet-
ric method. This method uses the mass, density, and dimensions of a
sample to calculate the porosity (equation below).Φ ¼ VE
VT
¼ 1 − 4·m
ρ·s·π·d2
;
with porosity Φ, empty volume VE in cm
3, total volume VT in cm
3,
mass m in g, polymeric density ρ in g/cm3, sample thickness s in cm,
and sample diameter d in cm.
The sample mass was determined with a high‐precision scale. For
determination of the thickness, the sample was cut in half in liquid
nitrogen with a razor blade. Images of the cutting edge were taken
with a scanning electron microscope (SEM, Hitachi S‐3400) and
analysed with an image analysis software (AxioVision, Carl Zeiss).
The pore diameter was determined with a capillary flow porometer
(3 Gzh, Quantachrome GmbH & Co.KG). Porofil® (Quantachrome
GmbH & Co.KG) was used as wetting liquid to spontaneous fill all
pores in the sample. The solid–gas interface was thereby replaced by
a solid–liquid interface. Pressure from a non‐reactant gas was gradu-
ally increased on the top side of the sample. When the energy of
the non‐reactant gas exceeds the interfacial free energy of the
solid/liquid interface, Porofil® was replaced by the non‐reactant gas.
Gas flow occurs through the largest pore of the sample (Jena & Gupta,
2001). Further pressure increase emptied smaller pores.
The software 3Gwin (Quantachrome GmbH & Co.KG) detected
the flow rate over the pressure. A wet (liquid‐filled) curve and a dry
(liquid‐free) curve were measured for each sample. From the collected
data, the pore diameter was calculated by the software using following
equation:
D ¼ 4 γcos θ
p
:
Where D is the pore diameter, γ the surface tension of the wetting
liquid, θ the contact angle of the wetting liquid, and p the differential
pressure (Li, Frey, & Joo, 2006).
2.3 | Experimental protocol
Twenty‐six Lewis/Han Ztm rats were equipped with femur chambers.
Scaffolds consisting of either a porous polymer patch (control; n = 8)
or unmodified PCL fibre mats (PCL; n = 9) or chitosan (CS)‐graft‐PCL
modified electrospun PCL fibre mats (CS‐g‐PCL; n = 9) were
implanted. Intravital fluorescence microscopy (IVM) analysis of
volumetric blood flow, wall shear rate, leukocyte–endothelial cell
interaction, macromolecular leakage, and functional capillary density
were performed immediately as well as 3, 6, 10, 14, 17, and 20 days
after implantation.
2.4 | Animals
All experiments were conducted in accordance with the German legis-
lation for the protection of animals and the Guide for the Care and
Use of Laboratory Animals (8th edition, 2011). The experiments were
approved by the competent authority (Niedersächsisches Landesamt
für Verbraucherschutz und Lebensmittelsicherheit, reference number
33.12‐42502‐04‐15/2015). Male Lewis rats with a body weight of
GNIESMER ET AL. 1193383 ± 65 g were used for the study with an age of 27 ± 12 weeks. All
animals were housed individually per cage at room temperature
between 22°C and 24°C and a relative humidity of 60–65% with a
12‐hr day–night cycle. The rats had free access to tap water and
standard pellet food (1328 Hybridpellet, Altromin, Lage/Westphalia,
Germany) at all times.2.5 | Anaesthesia
The preparation of the femur chamber and repeated IVM was exe-
cuted under inhalational anaesthesia (EZ‐7000 Classic System, PLEXX,
Elst/The Netherlands) by isoflurane. The animals were placed in an
induction chamber, and anaesthesia was induced with 5% isoflurane
(isoflurane, Isofluran CP®, 1 ml/ml, cp pharma, Burgdorf, Germany)
until loss of righting reflex. The anaesthesia depth was determined
with the aid of the toe pinch. After induction, the animals were placed
in lateral position on a heating mat to protect the animals against
hypothermia. Animals remained anaesthetized with the aid of a nose
cone with 2–3% isoflurane in oxygen.2.6 | Preparation of the rat femur chamber
The animals received a pain medication including butorphanol
(butorphanol, 0.05 mg/kg, Torbugesic 10 mg/ml, cp pharma, Burgdorf,
Germany) and carprofen (carprofen, 5 mg/kg, Carprosol 50 mg/ml, cp
pharma, Burgdorf, Germany) preoperatively. After shaving, depilating
and disinfection of the left hind limb, the skin was cut over the length
of the femur, and the musculature in this field was carefully separated
to expose the femur. As local anaesthesia lidocaine (lidocaine, 5 mg/kg,
Lidocainhydrochlorid 2%, bela‐pharm, Vechta, Germany) was applied
directly on the femur before fixation of the chamber frame (see
Figure 1 for details of the chamber design) and the trochanter major
was removed using a dental burr (Komet dental, Gebr. Brasseler GmbH
& Co. KG, Lemgo, Germany). Suture material (4‐0, Vicryl™Plus, braided,
absorbable, Johnson & Johnson Medical GmbH, Ethicon Deutschland,FIGURE 1 (a–c) Femur chamber. (a) The observation window (Ø10 mm) w
coverslip, which was secured by a circlip. The observation window was pr
chamber frame. (b) In vivo situation with an implant, which was fixed by s
implantation. (c) In vivo situation with attached chamber lid 17 days afterNorderstedt, Germany) was placed around the femur for later fixation
of the implant to the bone. The femur chamber (Figure 1) was attached
with two bone screws (MF‐corticalis screws, 1.3 × 4 mm, DePuy
Synthes, Johnson & Johnson Medical GmbH, Umkirch, Germany) dor-
sal and distal of the observation window. After filling the chamber with
physiological saline solution (NaCl 0.9%, B. Braun, Melsungen,
Germany), the chamber was closed with a cover glass (Ø10 mm,
Thermo Scientific, Braunschweig, Germany), which was fixed with a
circlip (Central Research Devices Service Unit, Hannover Medical
School, Hannover, Germany). The skin was adapted to the femur cham-
ber (5‐0 Ethilon*II, Polyamide, monofil, nonresorbable, Johnson &
Johnson Medical GmbH, Ethicon Deutschland, Norderstedt, Germany)
and sutured (4‐0, Vicryl™Plus, braided, absorbable, Johnson & Johnson
Medical GmbH, Ethicon Deutschland, Norderstedt, Germany). To pro-
tect the cover glass against manipulation by the rats, the observation
window was covered with a lid, which was fixed by two screws. The
rats were treated with antibiotics (enrofloxacin 5 mg/kg, Baytril
25 mg/ml, Bayer, Leverkusen, Germany) intraoperatively and per os
for 7 days and with analgetics (carprofen, 5 mg/kg, Rimadyl
50 mg/ml, Pfizer Deutschland GmbH, Berlin) for 2 days after surgery.
Postoperatively, the animals were given 3 days for convalescence
and adaption to the femur chamber before insertion of the implant
material. For implantation, the lid, the coverslip, and the cover glass
were removed. In anaesthesia, the implant material was inserted in
the centre of the observation window and fixed with the suture mate-
rial, which had been placed around the femur during operation. For this
purpose, the suture material is knotted over the implant. During the
experimental period, the animals were evaluated daily with a score‐
based evaluation system including the assessment weight loss, general
condition, spontaneous behaviour, clinical findings, and lameness.2.7 | Intravital fluorescence microscopy
For intravital microscopic observation of the microcirculation, the ani-
mals were anaesthetized as described above, and the left hind limbas fixed by two osteosynthesis screws to the bone and covered with a
otected with a chamber lid, fixed with two cylinder screws to the
uture material on the femur (chamber lid removed), 17 days after
implantation [Colour figure can be viewed at wileyonlinelibrary.com]
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an intravenous injection in the tail vein of 0.1 ml of 15% fluorescein‐
isothiocyanate‐labelled dextran (FITC‐dextran, MW 150,000; Sigma‐
Aldrich Chemie GmbH, Taufkirchen, Germany) in 0.9% NaCl (BBraun,
Melsungen, Germany) for contrast enhancement of blood plasma
and 0.1 ml of 0.1% rhodamine 6G (Sigma‐Aldrich Chemie GmbH,
Taufkirchen, Germany) in 0.9% NaCl (BBraun, Melsungen, Germany)
for direct observation of leukocytes.
IVM was performed by using a modified Zeiss microscope (Axio
Scope.A1, Carl Zeiss Microscopy GmbH, Göttingen, Deutschland),
microscope equipped with a 120‐W mercury lamp, and an illuminator
with blue and green filter blocks (Zeiss Microscopy, Göttingen,
Germany) for epi‐illumination of the microcirculation of striated mus-
culature. By using a charge‐coupled device video camera (FK‐7512‐
IQ, Pieper GmbH, Schwerte, Germany), the microscopic images were
recorded and transferred to a Blu‐ray recorder (JVC SR‐HD
1700/EU, JVC Kenwood Deutschland GmbH, Bad Vilbel, Germany)
for offline evaluation.2.8 | Analysis of microcirculatory parameters
The recorded data were analysed by means of the image analysis soft-
ware CapImage (CapImage 8.6.3., Zeintl, Heidelberg Germany).
Leukocyte–endothelial cell interactions, microhaemodynamics, and
macromolecular leakage were measured in four different regions of
interest in the border zone of the scaffold by using 2.5×, 10×, and
20× objectives resulting in 90×, 370×, and 940× magnification on
the monitor. In each region of interest, one venule in the granulation
tissue around the implant (inner diameter: 20–40 μm) was selected
and observed over 20 s for evaluation of vessel diameter, red blood
cell velocity, wall shear rate, and macromolecular leakage. The leuko-
cytes were classified according to their interaction with the vascular
endothelium as adherent, rolling, or free flowing cells. Adherent leuko-
cytes were cells that did not move or detach from the endothelial lin-
ing within an observation period of 20 s. Rolling leukocytes were
moving cells with a velocity less than two fifth of the centreline veloc-
ity. Diameters (d) were analysed in micrometres perpendicular to the
vessel path. The velocity (v) was measured using the line‐shift method
(T. Klyscz, 1997). Volumetric blood flow was calculated by





pl=s½ : For correction of the parabolic velocity pro-
file in microvessels, the Baker–Wayland factor 1.6 was used (Baker
& Wayland, 1974). Based on the Newtonian definition, the wall shear
rate was calculated by y ¼ 8 × v
d
. Macromolecular leakage was
analysed by means of grey levels in the tissue directly adjacent to
the venular vessel wall (E1) and in the marginal cell free plasma layer
within the blood vessel (E2). Extravasation (E) was calculated as
E = E1/E2. Microvessel density, defined as the length of blood vessels
per area of observation given in cm/cm2, was measured in the periph-
ery around the implant and in the centre of the implant. Both values
were displayed as the total functional capillary density expressed as
the sum of peripheral and central functional capillary density.2.9 | Histology and immunohistochemistry
At the end of the postoperative observation period of 20 days, animals
were finalized via cervical dislocation under deep anaesthesia, and his-
tological examinations were performed. Formalin‐fixed specimens of
the femur were embedded in Technovit 9100 (Willbold & Witte,
2010). Thin sections (5 μm) were stained with haematoxylin (Merck
KGaA, Darmstadt, Germany) and eosin (Merck KGaA, Darmstadt,
Germany) according to standard procedures. For histochemical detec-
tion of collagen fibres, we performed van Gieson staining of thin sec-
tions (5 μm) with haematoxylin (Merck KGaA, Darmstadt, Germany)
and picrofuchsia acid solution (Merck KGaA, Darmstadt, Germany)
according to standard procedures. All specimens were examined by
light microscopy (Leica DM4000 B, Leica Mikrosysteme, Wetzlar,
Germany).
For detection of capillaries, endothelial cells were
immunohistochemically stained using a rabbit anti‐rat CD34 antibody
(Hoelzel Diagnostika Handels GmbH, Koeln, Germany). As a secondary
antibody, a biotin conjugated antibody (DIANOVA GmbH, Hamburg,
Germany) was used. After incubation with streptavidin‐horseradish
peroxidase (DIANOVA GmbH, Hamburg, Germany), the colour devel-
opment after addition of 3.3′‐diaminobenzidine (Vector Laboratories,
Inc., Burlingame, CA, USA) was monitored microscopically followed
by counterstaining with haematoxylin. By omitting the primary anti-
body step, negative controls were performed, which all showed no
detectable staining.
By means of the marker enzyme, napthol‐AS‐D‐chloracetate‐
esterase neutrophilic granulocytes were determined. Sections were
first washed in distilled water and then incubated with naphthol AS‐
D chloroacetate (Sigma, Taufkirchen, Germany) in 4% pararosaniline
(Chroma, Olching, Germany) and 4% sodium nitrate in 0.1M acetate
buffer for 120 min. Sections were washed in distilled water and
mounted with Aquatex (Merck). Cells containing red‐brownish
granules were regarded as positive. Control sections were incubated
without the substrate. No staining developed in these controls.2.10 | Statistics
Results are expressed as means ± standard error of the mean (SEM).
Differences between groups were assessed by one‐way analysis of
variance (ANOVA), and differences within groups were analysed by
one‐way repeated measures ANOVA. To isolate differences between
pairs of groups, Student–Newman–Keuls post hoc tests were per-
formed. Differences were considered significant at p < .05.3 | RESULTS
3.1 | Properties of the material
The control group (porous polymer patch) showed very large pore
sizes of up to 175.34 μm and a high porosity (Table 1). Produced
PCL fibre mats show a non‐aligned structure as it can be seen in
TABLE 1 Fibre diameter in μm, porosity in %, maximum pore diam-
eter in μm, middle pore diameter in μm, and smallest pore diameter in
μm of the control group scaffold (control), the unmodified PCL fibre
mat group (PCL), and PCL fibre mat modified with a special fibre
modification utilizing chitosan group (CS‐g‐PCL)
Control PCL CS‐g‐PCL
Fibre diameter (μm) — 2.218 ± 0.516 2.421 ± 0.501









GNIESMER ET AL. 1195SEM images (Figure 2). It was found that the pure PCL had a porosity
of 80.61%. The maximum pore size (9.19 μm) was considerably lower
than for the control group (Table 1). Modification with the graft‐
copolymer CS‐g‐PCL reduced the porosity to 76.21% and simulta-
neously increased the fibre diameter (Table 1). This observation was
to be expected when applying a surface coating by crystallization to
the electrospun PCL fibres.3.2 | Animals
The animals showed no signs of discomfort or changes in behaviour.
Immediately after anaesthesia, the operated limbs were loaded again.
In the control group 1, animal was lost because of weight loss. In the
PCL group 1, animal was lost because of failure of chamber fixation.
In the CS‐g‐PCL group 3, animals were lost because of anaesthesia
and weight loss. These animals were not included in the statistical
evaluation.3.3 | Microhaemodynamic parameters
First, immediately after implantation and on Day 3,
microhaemodynamic parameters were not detectable by means of
IVM. The collected data including the diameter, the volumetric blood
flow, and the wall shear rate indicated that the different implant mate-
rials interfered with the microvascular blood flow of host tissue.FIGURE 2 Scanning electron microscope micrographs of (a) the porous p
mat, and (c) the CS‐g‐PCL fibre matVenular diameters stayed constant in all experimental groups ranging
between 14 and 19 μm (Table 2). Volumetric blood flow and wall
shear rates of venules were not significantly altered (Table 2).3.4 | Functional capillary density
Immediately after implantation and on Day 3, capillaries were not
observable by means of IVM. On Day 6, first results were visible in
the PCL group; however, in the other groups, no capillaries were
observed. The functional capillary density in the PCL group stayed
nearly constant over the evaluation period. The functional capillary
density caused by the control implant was comparable with that pro-
voked by the implantation of the unmodified fibre mat (PCL) and
showed a slight increase up to Day 14. This process stagnated at Days
17 and 20. In the CS‐g‐PCL group, we observed a significant increase
in functional capillary density at Day 10 compared with Day 6. At Day
14, the functional capillary density caused by the implantation of CS‐
g‐PCL was significantly increased compared with the control group
and the PCL group. At Days 17 and 20, the capillary density of CS‐
g‐PCL decreased and was at the level of the control and PCL
(Figure 3).3.5 | Inflammatory response
Evaluation of leukocyte endothelial interaction started at Day 6,
because they were not observable at earlier time points. The used
scaffolds induced only limited differences in leukocyte reaction
between the groups. In the PCL group, the number of rolling leuko-
cytes was significantly increased at Day 10 compared with the control
group and CS‐g‐PCL group. Afterwards, the number of rolling leuko-
cytes in the PCL group was decreased at Day 14 and stayed constant
until Day 20. The CS‐g‐PCL group showed nearly constant values
from Day 10 to Day 20 (Figure 4a). The number of adherent leuko-
cytes in the control group increased from Day 10 to Day 14. The con-
trol group also showed a significant increase of adherent leukocytes
compared with the groups PCL and CS‐g‐PCL at Day 14. In this group,
the adherent leukocytes decreased at Day 17 and stayed almost con-
stant until Day 20. The number of adherent leukocytes that was
observed for the PCL group showed a variable course during the eval-
uation period. There was an increase from Day 6 to Day 10, a steepolymer patch (control group), (b) the unmodified polycaprolactone fibre
TABLE 2 Venular diameters in μm, volumetric blood flow in pl/s, and wall shear rate in s−1 of postcapillary and collecting venules at the border
zones of the porous polymer patch control group (control), the unmodified PCL fibre mat group (PCL), and the chitosan‐modified PCL fibre mat
group (CS‐g‐PCL) 6, 10, 14, 17, and 20 days after implantation
Day 6 Day 10 Day 14 Day 17 Day 20
Diameter (μm)
Control 14.5 ± 0.0 18.2 ± 1.1 16.8 ± 1.4 15.9 ± 1.0 15.6 ± 1.4
PCL 17.0 ± 1.5 16.4 ± 0.9 17.2 ± 1.4 18.0 ± 1.2 16.6 ± 1.5
CS‐g‐PCL 14.0 ± 0.0 15.7 ± 1.5 18.9 ± 0.8 7.4 ± 7.3 15.0 ± 1.5
Shear rate (s−1)
Control 159.5 ± 0.0 236.0 ± 9.0 294.8 ± 30.0 245.8 ± 38.0 239.0 ± 62.4
PCL 137.6 ± 33.9 228.0 ± 49.6 141.3 ± 26.6 144.8 ± 28.7 120.0 ± 19.2
CS‐g‐PCL 174.6 ± 0.0 134.5 ± 39.1 181.9 ± 41.1 281.1 ± 0.0 232.1 ± 9.7
Volumetric blood flow (pl/s)
Control 30.1 ± 0.0 88.7 ± 15.1 90.6 ± 22.8 58.6 ± 7.8 53.2 ± 13.7
PCL 45.9 ± 16.6 59.5 ± 12.8 56.6 ± 23.7 61.7 ± 24.2 32.9 ± 5.9
CS‐g‐PCL 29.3 ± 0.0 32.7 ± 10.3 79.8 ± 22.1 54.7 ± 0.0 51.2 ± 13.2
Note. Values are expressed as means ± SEM.
Abbreviation: PCL, polycaprolactone.
1196 GNIESMER ET AL.decrease at Day 14, and again an increase until Day 20, which reached
nearly the value present at Day 10. In the Cs‐g‐PCL group, adherent
leukocytes could be observed beginning with Day 10. Compared with
the control group and the PCL group, the results were lower at Days
10 and 14, but from Day 10 to Day 17, there was an increase in the
number of adherent leukocytes. At Day 20, the adherent leukocytes
decreased in the CS‐g‐PCL group (Figure 4b).3.6 | Histology and immunohistochemistry
Haematoxylin–eosin‐staining showed obvious differences in cell infil-
tration depending on the implant material. Infiltration with cells
appeared uniform in the control group. In the PCL group, however,
ingrowth of cells was also detectable, but to a lesser extent compared
with the control group. The PCL group showed a clear cellular margin
with a kind of encapsulation (Figure 5e). In the CS‐g‐PCL group, the
histological findings were comparable, but there was barely no margin
around the implant present (Figure 5a–f).
Collagen fibres were visualized by van Gieson staining (Figure 5g–i).
Collagen fibres were histologically representable in the control group as
well as in the experimental groups. The control group showed an equal
distribution of orientated collagen fibres around the implant structure.
The PCL group showed collagen fibres especially in the border area of
the implant, which were less prominent compared with the control
group. In the CS‐g‐PCL group, only a few collagen fibres around the
implant could be demonstrated.
A semiquantitative analysis of foreign body giant cells (FBGC;
Figure S1) revealed the highest number of FBGC around the unmodi-
fied PCL implants. In the control group and the CS‐G‐PCL group, the
count of FBGC was comparably low.Immunohistochemical examination with CD34‐based detection of
vascular structures at Day 20 was applied to verify the results
obtained with IVM. Highly vascularized granulation tissue around the
implant was detectable in the control group and the group with CS‐
g‐PCL fibre mats. The unmodified PCL fibre mats were surrounded
by granulation tissue, which showed a lower vessel density. It should
be emphasized that in the CS‐g‐PCL group, vessels within the implant
material were also detectable (Figure 5d–f), which was not the case for
the PCL group. To further characterize the cellular margin visible
around the PCL fibre mats, a napthol‐AS‐D‐chloracetate‐esterase
staining was applied to detect neutrophilic granulocytes. This cell type
was present in all groups, but especially the PCL fibre mats (PCL and
CS‐g‐PCL) showed a high infiltration of neutrophilic granulocytes
(Figure 6).4 | DISCUSSION
In this study, using the femur chamber in rats, we demonstrated that
CS‐g‐PCL modification of PCL fibre mats improved angiogenesis
in vivo. Currently, tissue regeneration after defects independent of
the field of application is limited by the absence of proven strategies
for the generation of adequately vascularized tissues (Schumann
et al., 2011). Sufficient perfusion is important for oxygen supply, nutri-
tion of cells and tissues when cellular ingrowth in scaffolds shall be
achieved, and for removal of metabolites (Lovett et al., 2009). There-
fore, it is of great importance to gather knowledge about the extent
and time course of vascularization of different implant materials
before they can be successfully used in a clinical setting (Laschke
et al., 2006).
The modification of the PCL fibre mats with CS‐g‐PCL showed a
marked improvement in angiogenesis in the first 2 weeks after
FIGURE 3 Neovascularization in the femur chamber model: (a–c) Representative intravital fluorescence microscopy overview images of (a)
control, (b) polycaprolactone, and (c) CS‐g‐PCL 20 days after implantation. The centres of the implants are marked (#). (d–f) Quantification of
neovascularization expressed as functional capillary density in cm/cm2 (d) in the border zones of the implants, (e) in the centre of the implants, and
(f) total functional capillary density expressed as the sum of peripheral and central functional capillary density. All values in this figure represent the
mean ± SEM
GNIESMER ET AL. 1197implantation compared with the unmodified mats and the control
group. Particularly in the early phase, rapid development of vessels
for supply of ingrowing cells is important. Only then the survival of
the immigrant cells and thus the survival of the implant secured. Ves-
sels were detected at Day 6 onwards in this model although angiogen-
esis was expected to start sooner (Carmeliet, 2000; Ke & Costa, 2006).
Studies in the dorsal skinfold chamber in mice and hamsters showed
that angiogenesis already had increased on Day 3 (Zimmerer et al.,
2017). Whereas in the femur chamber in mice, which is a hard tissuemodel and therefore maybe the better comparison, results on angio-
genesis were also obtained from Day 6 (Tavassol et al., 2011). Angio-
genesis is the complex and tightly regulated process of formation of
new capillaries from existing blood vessels (Laschke et al., 2006). After
an injury, acute necrosis and hypoxia occur in the affected area. The
local oxygen concentration regulates the expression of the angiogenic
factor VEGF via hypoxia‐inducible factor‐1α (Laschke et al., 2006;
Norrby, 1997). A reason for the finding that we could observe first
signs of angiogenesis beginning from Day 6 might be the surgical
FIGURE 4 Leukocyte–endothelium interaction at the periphery of
the implants in postcapillary and collecting venules after
implantation. (a) Number of rolling leukocytes 6, 10, 14, 17, and
20 days after implantation shown as number of cells/min. (b) Number
of adherent leukocytes 6, 10, 14, 17, and 20 days after implantation
shown as number of cells/mm2. All values in this figure represent the
mean ± SEM
1198 GNIESMER ET AL.procedure. Compared with the dorsal skinfold chamber, the prepara-
tion of the femur chamber is more invasive; therefore, a longer regen-
eration period after preparation of the chamber is needed. Within the
chamber, blood and debris must be removed before vessels were
observable. The course of the functional capillary density showed a
good vascular supply from Day 10 to Day 14 after implantation. The
decline from Day 17 is explainable considering the growth and devel-
opment of vessels by the beginning of a remodelling process, which
results later in the formation of a structured network of vessels
(Carmeliet, 2000). By determining the functional capillary density in
the length of the vessels per area, this results in a smaller value. Many
small vessels were measured by Day 14. By remodelling the intravital
microscopic examination showed fewer but larger vessels.
Modification of PCL with chitosan is often used to enhance bio-
compatibility of PCL‐based scaffolds for different tissue engineering
approaches. This can be achieved either by first modifying the poly-
mers and generating scaffolds via electrospinning as a consecutive
step (Chen, Huang, Yu, Liu, & Gu, 2011) or, as with the CS‐g‐PCL scaf-
fold in this study, as a secondary modification after electrospinning of
PCL. This modification resulted in an increased in vitro biocompatibil-
ity in terms of enhanced cell attachment and growth compared withuncoated PCL fibre mats (de Cassan et al., 2018). In the present study,
these data were supported by our in vivo data in reference to biocom-
patibility and angiogenesis. In contrast to the PCL group, which
showed a prominent fibrous capsule, the CS‐g‐PCL group showed
only a minor deposition of collagen fibres around the implant and
the lowest amount of FBGC proofing the good biocompatibility
achieved by the chitosan modification. The number of FBGC was com-
parable in the control group, but there was a higher deposition colla-
gen with orientated fibres, which may be a hint of a stronger foreign
body reaction. With respect to the short observation period after
implantation, this is just a hypothetical assumption, which should be
proven in further studies.
Although we could show an enhanced angiogenesis as a reaction
to the implantation of PCL‐based scaffolds, there is still a lack of ves-
sels inside the PCL‐based scaffolds. Only in the CS‐g‐PCL group ves-
sels were detectable inside the scaffold. A crucial factor for the
vascularization of implants and the ingrowth of cells is the porosity
of the implant. In a study using the mice skinfold chamber model
and intravital microscopy, a pore size of approximately 250–300 μm
was found to promote the best vascularization of poly(ether ester)
block‐copolymer scaffolds (Druecke et al., 2004). In this study, the
authors also showed that the effect of pore size is more prominent
in the centre of the implant. Implants with a larger pore size showed
a higher functional capillary density in the border zone at early time
points, but later, there was no difference between the different pore
sizes observable. This effect is also present in our study: At later time
points, the functional capillary density is comparable in all groups in
the border zone of the implants. At the centre of the implants, we
observed differences between the groups also at later time points.
Taking the development of the granulation tissue into account, this
result can be explained. We assume that development of the granula-
tion tissue originated from the tissue underneath the implants
resulting in a faster growth in the border zone of the implants.
Because of the larger pore size, tissue growth through the pores of
the implants was only observed to a larger extent in the control group.
In the CS‐g‐PCL group, we detected a limited ingrowth of capillaries,
whereas we detected no vascular ingrowth into the implants of the
PCL group. From this observation, one would assume that the func-
tional capillary density in the centre will reach the highest value in
the control group, but our results showed that functional density in
the centre reached the highest values in the CS‐g‐PCL group. This
finding reflects the good biocompatibility of these implants accom-
plished by the chitosan modification and may be due to an accelerated
growth of granulation tissue that rapidly enwrapped the implant. Fur-
ther developments of the CS‐PCL scaffolds may be needed to further
enhance the ingrowth of vessels. To achieve this aim, various
approaches are possible. One possibility is the addition of angiogenic
growth factors, which trigger vessel growth. Release of VEGF from
porous PCL‐based scaffolds caused an enhancement of angiogenesis,
which led to a higher ingrowth of vessels into depth of the scaffold
(Singh, Wu, & Dunn, 2012), and more mechanistic approaches are pos-
sible. Vascularization of scaffolds depends to a large extend on the
accessibility of the inner parts of the scaffold for growing vessels.
FIGURE 5 HE staining, van Gieson staining, and immunohistochemical detection of CD 34: Representative histological stainings (a–o) 20 days
after implantation into the femur chamber in Lewis rats. (a–c) HE staining of (1) granulation tissue, (2) implant, and (3) bone. (d–f) HE staining with
higher magnification. (g–i) Collagen fibres were detected by van Gieson staining. (j–l) The presence of endothelial cells and accordingly the
presence of vascular structures were confirmed by immunohistochemical detection of CD34. (m–o) Negative controls. Areas of the implant are
marked (#), and arrows denote vascular structures [Colour figure can be viewed at wileyonlinelibrary.com]
GNIESMER ET AL. 1199With respect to electrospun scaffolds, an increase in pore size can be
achieved via the inclusion of sacrificial fibres of a water soluble poly-
mer during the spinning process (Phipps, Clem, Grunda, Clines, &
Bellis, 2012). These fibres were removed after production of the scaf-
fold leading to a larger mean pore size, which in turn facilitates the
ingrowth of cells. Larger pores can be generated by means of laser cut-
ting. Increasing diameters of pores enhanced the vascularization of
scaffolds and in turn resulted in a better cellular infiltration (Joshi,
Lei, Walthers, Wu, & Dunn, 2013). This effect is also influenced by
the overall porosity. The higher the content of macropores was, the
more blood vessels inside the scaffold and infiltrating cells could be
detected (Walthers, Nazemi, Patel, Wu, & Dunn, 2014). With regard
to our study, we assume that a further enhancement of angiogenesis
and particularly of cell infiltration into the CS‐g‐PCL scaffold could
be induced by enhancing the porosity and pore size of the scaffold.
This could be achieved via the generation of macropores or by
using larger fibre diameters, which in turn also will result in
enhanced mechanical properties of the scaffolds, as was shown by
Wang et al. (2014).
Different models for assessing the angiogenic and inflammatory
reaction after the implantation of different materials have been
established so far. Most of these models are performed using mice
(Burghartz et al., 2015) or rats (Seyednejad et al., 2012) and are char-
acterized by a final point at which the samples are examined. How-
ever, these end point models cannot generate any information
regarding the changes in the vasculature over the time course of the
experiment. To explore the angiogenic and inflammatory reaction of
soft tissues, the dorsal skinfold chamber is a widely used model
(Kampmann et al., 2013). As a comparable model for the investigationof vascularization and biocompatibility in hard tissues, the femur
chamber in mice, which allowed to place implants in the immediate
environment of the femur, was established (Tavassol et al., 2011). In
the present study, we used a model, which was adapted to the femur
of rats. In contrast to the mouse femur chamber in the rat model, no
bone defect was created. Instead, the implant was fixed by means of
suture material to the bone. The area in which the trochanter major
was removed is only for fixation of the chamber and is not in the
observation window. There was no bone defect in the observation
area in the bone. This preparation method may have affected the mea-
sured parameters, as the periosteum may be injured by manipulation
during surgery. Nevertheless, the results provide important informa-
tion about vascularization of implants in bony environment, because
even in patients, the periosteum may already be injured by rupture
of the tendon or is damaged during surgical procedure. The femur
chamber was characterized by an observation chamber, which permit-
ted a steady microscopic view of the implanted scaffold without dis-
turbance of the growing tissue and therefore the study of the hard
tissue reaction repeatedly in the same animal over an evaluation
period of 20 days. Furthermore, by recording leucocyte endothelial
interactions, we could also generate data about the local inflammatory
response to the scaffold implantation, which is also not possible with
standard end point models.
As a control group, a commercial porous polymer patch was used,
which has a proven biocompatibility. Despite the fact that the material
parameters of the control group markedly differ from experimental
groups, this material was chosen, because earlier studies confirmed
the improvement of mechanical properties using this patch for rotator
cuff tear repair (Ricchetti, Aurora, Iannotti, & Derwin, 2012). In the
FIGURE 6 Chloracetate‐esterase staining for detection of neutrophilic granulocytes: Representative histological stainings 20 days after
implantation into the femur chamber in rats (#) implant [Colour figure can be viewed at wileyonlinelibrary.com]
1200 GNIESMER ET AL.experimental groups, PCL, which is well known for its biocompatibility,
was used to fabricate electrospun fibre mats. During electrospinning,
undirected fibres were produced mimicking the structure of unaligned
collagen fibres of the bone. In addition, the process of electrospinning
increased the mechanical stability, because unprocessed PCL is not
sufficient for load bearing applications (Agrawal & Ray, 2001).
In conclusion, graft copolymer modification showed improved
vascularization compared with the unmodified material. The approach
of this study is promising for clinical use of CS‐g‐PCL‐based implants
in various clinical applications, after further examination of the CS‐g‐
PCL implants in small and large animals.ACKNOWLEDGEMENTS
This research project has been supported by the DFG FOR 2180
“Gradierte Implantate für Sehnen‐Knochen‐Verbindungen” (KA
4236/1‐1). We acknowledge the excellent technical assistance of
Stefanie Rausch.CONFLICT OF INTEREST
The authors confirm that there are no known conflicts of interest




Agrawal, C. M., & Ray, R. B. (2001). Biodegradable polymeric scaffolds for
musculoskeletal tissue engineering. Journal of Biomedical Materials
Research, 55, 141. https://doi.org/10.1002/1097‐4636(200105)55:2
<141::AID‐JBM1000>3.0.CO;2‐J–150.
Apostolakos, J., Durant, T. J., Dwyer, C. R., Russell, R. P., Weinreb, J. H.,
Alaee, F., … Mazzocca, A. D. (2014). The enthesis: A review of the
tendon‐to‐bone insertion. Muscles, Ligaments and Tendons Journal.
CIC Edizioni Internazionali, 4(3), 333–342. Available at: http://www.
ncbi.nlm.nih.gov/pubmed/25489552. Accessed: 27 February 2018
GNIESMER ET AL. 1201Baker, M., & Wayland, H. (1974). On‐line volume measurement flow rate
and velocity profile for blood in microvessels. Microvascular Research,
7, 131–143. https://doi.org/10.1016/0026‐2862(74)90043‐0
Boileau, P., Brassart, N., Watkinson, D. J., Carles, M., Hatzidakis, A. M., &
Krishnan, S. G. (2005). Arthroscopic repair of full‐thickness tears of
the supraspinatus: Does the tendon really heal? Journal of Bone and
Joint Surgery ‐ Series A., 87, 1229. https://doi.org/10.2106/JBJS.
D.02035
Burghartz, M., Gehrke, T., Storck, K., Staudenmaier, R., Mandlik, V., Schurr,
C., … Kleinsasser, N. (2015). Vascularization of engineered cartilage
constructs in a mouse model. Cell and Tissue Research, 359(2),
479–487. https://doi.org/10.1007/s00441‐014‐2026‐2
Carmeliet, P. (2000). Mechanisms of angiogenesis and arteriogenesis.
Nature Medicine, 6(4), 389–395. https://doi.org/10.1038/74651
Chen, H., Huang, J., Yu, J., Liu, S., & Gu, P. (2011). Electrospun chitosan‐
graft‐poly(ɛ‐caprolactone)/poly(ɛ‐caprolactone) cationic nanofibrous
mats as potential scaffolds for skin tissue engineering. International
Journal of Biological Macromolecules, 48(1), 13–19. https://doi.org/
10.1016/j.ijbiomac.2010.09.019
Dash, T. K., & Konkimalla, V. B. (2012). Poly‐є‐caprolactone based formu-
lations for drug delivery and tissue engineering: A review. Journal of
Controlled Release, 158(1), 15–33. https://doi.org/10.1016/j.
jconrel.2011.09.064
de Cassan, D., Sydow, S., Schmidt, N., Behrens, P., Roger, Y., Hoffmann, A.,
… Menzel, H. (2018). Attachment of nanoparticulate drug‐release sys-
tems on poly(ε‐caprolactone) nanofibers via a graftpolymer as
interlayer. Colloids and Surfaces. B, Biointerfaces Elsevier, 163,
309–320. https://doi.org/10.1016/J.COLSURFB.2017.12.050
Druecke, D., Langer, S., Lamme, E., Pieper, J., Ugarkovic, M., Steinau, H. U.,
& Homann, H. H. (2004). Neovascularization of poly (ether ester) block‐
copolymer scaffolds in vivo: Long‐term investigations using intravital
fluorescent microscopy. Journal of Biomedical Materials Research. Part
A, 68(1), 10–18. https://doi.org/10.1002/jbm.a.20016
Encalada‐Diaz, I., Cole, B. J., MacGillivray, J. D., Ruiz‐Suarez, M., Kercher, J.
S., Friel, N. A., & Valero‐Gonzalez, F. (2011). Rotator cuff repair aug-
mentation using a novel polycarbonate polyurethane patch:
Preliminary results at 12 months' follow‐up. Journal of Shoulder and
Elbow Surgery, 20(5), 788. https://doi.org/10.1016/j.jse.2010.08.013
Ferracini, R., Martínez Herreros, I., Russo, A., Casalini, T., Rossi, F., & Perale,
G. (2018). Scaffolds as structural tools for bone‐targeted drug delivery.
Pharmaceutics, 10(3), 1–26. https://doi.org/10.3390/pharmaceutics
10030122
Font Tellado, S., Balmayor, E. R., & Griensven, M. (2015). Strategies to
engineer tendon/ligament‐to‐bone interface: Biomaterials, cells and
growth factors. Advanced Drug Delivery Reviews Elsevier, 94,
126–140. https://doi.org/10.1016/J.ADDR.2015.03.004
Fu, X., Sammons, R. L., Bertóti, I., Jenkins, M. J., & Dong, H. (2011). Active
screen plasma surface modification of polycaprolactone to improve cell
attachment’. Journal of Biomedical Materials Research Part B: Applied Bio-
materials. Wiley‐Blackwell, 100B(2), 314–320. https://doi.org/
10.1002/jbm.b.31916
Gerber, C., Meyer, D. C., Frey, E., von Rechenberg, B., Hoppeler, H., Frigg,
R., … Zumstein, M. A. (2009). Neer Award 2007: Reversion of structural
muscle changes caused by chronic rotator cuff tears using continuous
musculotendinous traction. An experimental study in sheep. Journal of
Shoulder and Elbow Surgery, 18, 163. https://doi.org/10.1016/j.
jse.2008.09.003–171.
Gerber, C., Meyer, D. C., Schneeberger, A. G., Hoppeler, H., & Von
Rechenberg, B. (2004). Effect of tendon release and delayed repair on
the structure of the muscles of the rotator cuff: An experimental studyin sheep. The Journal of Bone and Joint Surgery. American, 86‐A(9),
1973–1982. doi: 86/9/1973 [pii]
Giai Via, A., De Cupis, M., Spoliti, M., & Oliva, F. (2013). Clinical and biolog-
ical aspects of rotator cuff tears. Muscles, Ligaments and Tendons
Journal, 3(2), 70–79. Available at: https://www.ncbi.nlm.nih.gov/pmc/
articles/PMC3711705/pdf/70‐79.pdf. Accessed: 27 February 2018
Gulotta, L. V., Kovacevic, D., Packer, J. D., Deng, X. H., & Rodeo, S. A.
(2011). Bone marrow–derived mesenchymal stem cells transduced
with scleraxis improve rotator cuff healing in a rat model. The American
Journal of Sports Medicine, 39(6), 1282–1289. https://doi.org/10.1177/
0363546510395485
Jena, A., & Gupta, K. (2001). An innovative technique for pore structure
analysis of fuel cell and battery components using flow porometry.
Journal of Power Sources, 96, 214–219. https://doi.org/10.1016/
S0378‐7753(00)00684‐4
Joshi, V. S., Lei, N. Y., Walthers, C. M., Wu, B., & Dunn, J. C. (2013).
Macroporosity enhances vascularization of electrospun scaffolds. The
Journal of Surgical Research., 183(1), 18–26. https://doi.org/10.1016/j.
jss.2013.01.005
Jost, B., Zumstein, M., Pfirrmann, C. W., & Gerber, C. (2006). Long‐term
outcome after structural failure of rotator cuff repairs. Journal of Bone
and Joint Surgery ‐ Series A., 88, 472. https://doi.org/10.2106/JBJS.
E.00003
Kampmann, A., Lindhorst, D., Schumann, P., Zimmerer, R., Kokemüller, H.,
Rücker, M., … Tavassol, F. (2013). Additive effect of mesenchymal stem
cells and VEGF to vascularization of PLGA scaffolds. Microvascular
Research Academic Press, 90, 71–79. https://doi.org/10.1016/J.
MVR.2013.07.006
Ke, Q., & Costa, M. (2006). Hypoxia‐inducible factor‐1 (HIF‐1). Molecular
Pharmacology, 70(5), 1469 LP–1480. Available at: http://molpharm.
aspetjournals.org/content/70/5/1469.abstract
Klyscz, T. (1997). Cap image‐a new kind of computer‐assisted video image
analysis system for dynamic capillary microscopy. Biomedizinische
Technik. Biomedical Engineering, 42, 168–175. https://doi.org/
10.1515/bmte.1997.42.6.168
Lam, C. X. F., Hutmacher, D. W., Schantz, J. T., Woodruff, M. A., & Teoh, S.
H. (2008). Evaluation of polycaprolactone scaffold degradation for 6
months in vitro and in vivo. Journal of Biomedical Materials Research ‐
Part A, 90, 906. https://doi.org/10.1002/jbm.a.32052–919.
Laschke, M. W., Harder, Y., Amon, M., Martin, I., Farhadi, J., Ring, A., … &
Häufel, J. M. (2006) Angiogenesis in tissue engineering: Breathing life
into constructed tissue substitutes. Available at: http://online.
liebertpub.com/doi/pdfplus/10.1089/ten.2006.12.2093 (Accessed: 27
February 2018).
Li, D., Frey, M. W., & Joo, Y. (2006). Characterization of nanofibrous mem-
branes with capillary flow porometry. Journal of Membrane Science, 286,
104–114. https://doi.org/10.1016/j.memsci.2006.09.020
Lovett, M., Lee, K., Edwards, A., & Kaplan, D. L. (2009). Vascularization
strategies for tissue engineering. Tissue Engineering. Part B, Reviews.
Mary Ann Liebert, Inc., 15(3), 353–370. https://doi.org/10.1089/ten.
TEB.2009.0085
Lu, H. H., & Thomopoulos, S. (2013). Functional attachment of soft tissues
to bone: Development, healing, and tissue engineering. Annual Review
of Biomedical Engineering NIH Public Access, 15, 201–226. https://
doi.org/10.1146/annurev‐bioeng‐071910‐124656
Meyer, D. C., Gerber, C., von Rechenberg, B., Wirth, S. H., & Farshad, M.
(2011). Amplitude and strength of muscle contraction are reduced in
experimental tears of the rotator cuff. The American Journal of Sports
Medicine., 39, 1456–1461. https://doi.org/10.1177/036354651
0396305
1202 GNIESMER ET AL.Meyer, D. C., Wieser, K., Farshad, M., & Gerber, C. (2012). Retraction of
supraspinatus muscle and tendon as predictors of success of rotator
cuff repair. The American Journal of Sports Medicine., 40, 2242–2247.
https://doi.org/10.1177/0363546512457587
Nair, L. S., & Laurencin, C. T. (2007). Biodegradable polymers as biomate-
rials. Progress in Polymer Science, 32(8), 762–798. https://doi.org/
10.1016/j.progpolymsci.2007.05.017
Norrby, K. (1997). Angiogenesis: New aspects relating to its initiation and
control. APMIS Wiley Online Library, 105(1–6), 417–437. https://doi.
org/10.1111/j.1699‐0463.1997.tb00590.x
Phipps, M. C., Clem, W. C., Grunda, J. M., Clines, G. A., & Bellis, S. L. (2012).
Increasing the pore sizes of bone‐mimetic electrospun scaffolds com-
prised of polycaprolactone, collagen I and hydroxyapatite to enhance
cell infiltration. Biomaterials, 33(2), 524–534. https://doi.org/
10.1016/j.biomaterials.2011.09.080
Ricchetti, E. T., Aurora, A., Iannotti, J. P., & Derwin, K. A. (2012). Scaffold
devices for rotator cuff repair. Journal of Shoulder and Elbow Surgery
Mosby, 21(2), 251–265. https://doi.org/10.1016/J.JSE.2011.10.003
Rodeo, S. A. (2007). Biological augmentation of rotator cuff tendon repair.
Journal of Shoulder and Elbow Surgery, 16, 191S. https://doi.org/
10.1007/s11999‐007‐0112‐4–633S.
Rücker, M., Laschke, M. W., Junker, D., Carvalho, C., Schramm, A.,
Mülhaupt, R., … Menger, M. D. (2006). Angiogenic and inflammatory
response to biodegradable scaffolds in dorsal skinfold chambers of
mice. Biomaterials Elsevier, 27(29), 5027–5038. https://doi.org/
10.1016/J.BIOMATERIALS.2006.05.033
Schumann, P., von See, C., Kampmann, A., Lindhorst, D., Tavassol, F.,
Kokemüller, H., … Rücker, M. (2011). Comparably accelerated vascular-
ization by preincorporation of aortic fragments and mesenchymal stem
cells in implanted tissue engineering constructs. Journal of Biomedical
Materials Research Part A. Wiley Subscription Services, Inc., A Wiley
Company, 97A(4), 383–394. https://doi.org/10.1002/jbm.a.33069
Seyednejad, H., Gawlitta, D., Kuiper, R. V., de Bruin, A., van Nostrum, C. F.,
Vermonden, T., … Hennink, W. E. (2012). In vivo biocompatibility and
biodegradation of 3D‐printed porous scaffolds based on a hydroxyl‐
functionalized poly(ε‐caprolactone). Biomaterials, 33(17), 4309–4318.
https://doi.org/10.1016/j.biomaterials.2012.03.002
Singh, S., Wu, B. M., & Dunn, J. C. Y. (2012). Delivery of VEGF using
collagen‐coated polycaprolactone scaffolds stimulates angiogenesis.
Journal of Biomedical Materials Research. Part A., 100(3), 720–727.
https://doi.org/10.1002/jbm.a.34010
Sinikovic, B., Schumann, P., Winkler, M., Kuestermeyer, J., Tavassol, F., von
See, C., … Rücker, M. (2011). Calvaria bone chamber—A new model for
intravital assessment of osseous angiogenesis. Journal of Biomedical
Materials Research Part A. Wiley‐Blackwell, 99A(2), 151–157. https://
doi.org/10.1002/jbm.a.32955
Tallawi, M., Rosellini, E., Barbani, N., Cascone, M. G., Rai, R., Saint‐Pierre,
G., & Boccaccini, A. R. (2015). Strategies for the chemical and biological
functionalization of scaffolds for cardiac tissue engineering: A review.
Journal of the Royal Society Interface, 12(108), 20150254. https://doi.
org/10.1098/rsif.2015.0254Tavassol, F., Kampmann, A., Schumann, P., Lindhorst, D., Kokemüller, H.,
Essig, H., … Gellrich, N. C. (2011). A novel approach for studying micro-
circulation in bone defects by intravital fluorescence microscopy.
Tissue Engineering Part C: Methods., 17, 1151–1159. https://doi.org/
10.1089/ten.tec.2011.0065
Venugopal, J., Ma, L. L., Yong, T., & Ramakrishna, S. (2005). In vitro study of
smooth muscle cells on polycaprolactone and collagen nanofibrous
matrices. Cell Biology International, 29, 861–867. https://doi.org/
10.1016/j.cellbi.2005.03.026
Walthers, C. M., Nazemi, A. K., Patel, S. L., Wu, B. M., & Dunn, J. C. (2014).
The effect of scaffold macroporosity on angiogenesis and cell survival
in tissue‐engineered smooth muscle. Biomaterials, 35(19), 5129–5137.
https://doi.org/10.1016/j.biomaterials.2014.03.025
Wang, Z., Cui, Y., Wang, J., Yang, X., Wu, Y., Wang, K., … Zhu, Y. (2014).
The effect of thick fibers and large pores of electrospun poly(ε‐
caprolactone) vascular grafts on macrophage polarization and arterial
regeneration. Biomaterials, 35(22), 5700–5710. https://doi.org/
10.1016/j.biomaterials.2014.03.078
Willbold, E., & Witte, F. (2010). Histology and research at the hard tissue–
implant interface using Technovit 9100 New embedding technique.
Acta Biomaterialia Elsevier, 6(11), 4447–4455. https://doi.org/
10.1016/J.ACTBIO.2010.06.022
Zelzer, E., Blitz, E., Killian, M. L., & Thomopoulos, S. (2014). Tendon‐to‐
bone attachment: From development to maturity. Birth Defects
Research. Part C, Embryo Today: Reviews. NIH Public Access, 102(1),
101–112. https://doi.org/10.1002/bdrc.21056
Zimmerer, R. M., Ludwig, N., Kampmann, A., Bittermann, G., Spalthoff, S.,
Jungheim, M., … Tavassol, F. (2017). CD24+ tumor‐initiating cells from
oral squamous cell carcinoma induce initial angiogenesis in vivo. Micro-
vascular Research Academic Press, 112, 101–108. https://doi.org/
10.1016/J.MVR.2017.03.006
SUPPORTING INFORMATION
Additional supporting information may be found online in the
Supporting Information section at the end of the article.
Figure S1. Representative van Gieson stainings demonstrating foreign
body giant cells (FBGC) in the control group (A), PCL‐group (B) and CS‐
g‐PCL group (C). Arrows denote FBGC. For semiquantitative analysis
(D) ten excerpts were assessed in three histological cuts each for each
implant.
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